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Article Information  ABSTRACT 
Received: 25th May 2017  Acne vulgaris or acne is a multi factorial chronic inflammatory disease of pilosebaceous unit. 
Globally it affects approximately 9.4% of the population. It is characterized by blackheads and 
white heads, pinheads, large papules which may lead to scarring. Other than scarring, its main 
effects are psychological, such as distress and reduced self-esteem. Up to 80% of teenage girls 
and 90% of teenage boys are afflicted with acne. Adult acne, although less common than 
adolescent acne, is a significant problem for 3% to 6% of adult men and 5% to 12% of adult 
women. It is the most common chronic skin disorders which require urgent attention. Successful 
treatment of acne requires careful selection of anti-acne agents. 
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INTRODUCTION 
Acne vulgaris is a common chronic skin disease involving 
blockage and/or inflammation of pilosebaceous units (hair 
follicles along with sebaceous gland) [1]. It appears as non 
inflammatory lesions such as microcomedones and 
inflammatory lesions such as papules and pustules or a mixture 
of both. It mainly affects the areas of skin with the densest 
population of sebaceous follicles eg. face, upper chest and back 
[2]. The individuals may also suffer with severe nodular acne 
which may lead to pain as well as both physical and 
psychological scarring. Apart from scarring, its main effects 
include social embarrassment, reduction in self-confidence [3] 
and in very extreme cases, depression or suicide [4]. One study 
has estimated the incidence of suicidal ideation in patients with 
acne as 7.1% [5]. Acne affects mainly during adolescence, It 
was estimated that approximately 80–90% of teenagers are 
affected with acne [6-8]. Low rates are reported in rural 
societies [9]. In 2010 it was estimated to be the 8th most 
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common disease globally affecting 650 million people [10]. 
Although acne diminishes over time and tends to decline by 
age of 25 [11] but some individuals remain affected beyond 
their thirties and forties [12]. Successful management of acne 
needs careful selection of anti-acne agents according to clinical 
presentation and individual patient needs [13][14]  
 
SYMPTOMS OF ACNE 
Acne vulgaris (or simply acne) is characterized by [15] : 
 areas of seborrhea (scaly red skin), 
 comedones (blackheads and whiteheads),  
 papules (pinheads), nodules (large papules), 
 pimples and ultimately scarring. 
Other symptoms may include pain, tenderness or erythema 
depending upon the severity of disease. 
 
Figure 1: acne on back [16] 
 
Figure 2 :Acne on face [17] 
Systemic symptoms are most often absent in acne vulgaris. 
Severe acne with associated systemic signs and symptoms, 
such as fever, is referred to as acne fulminans. Severe acne, 
characterized by multiple comedones, without the presence of 
systemic symptoms, is known as acne conglobata. This severe 
form of acne frequently heals with disfiguring scars. Moreover 
acne has psychological impact depending on the severity or 
grade of the disease [18] 
 
TYPES OF ACNE (On the basis of diagnosis) 
On the basis of diagnosis and severity of condition acne can be 
classified as mild, moderate, or severe [2]. It includes: 
 Comedonal acne: This may be characterized by presence of 
open (blackheads) and closed (whiteheads) comedones but 
no signs of any inflammatory papules or nodules. 
 Mild acne: It includes the presence of comedones with 
occasionally inflammatory lesions. Open and closed 
comedones mostly limited to the face [2] 
 Moderate acne: It includes presence of comedones, 
inflammatory papules and pustules. Inflammatory lesions are 
more than in mild inflammatory acne and these involve face 
as well as the trunk of the body [2] 
 Severe nodular acne: It may be characterized as presence of 
comedones, inflammatory lesions, and large nodules. These 
nodules (the painful 'bumps' lying under the skin) are 
generally greater than 5 mm in diameter. These may also 
lead to scarring. The nodules are present on face and trunk. 
These were also considered cysts so this type is also termed 
as nodulocystic acne [19] 
 
CAUSES OF ACNE 
Acne appear mostly in young people due to several factors [22] 
 hormonal imbalances (overproduction of the male sex 
hormones), 
 bacterial infection, 
 heredity or genetics, 
 consumption of certain drugs (including androgens and 
barbiturates) 
 exposure to environmental irritants (such as pollution and 
high humidity), 
 stress, 
 cosmetic application, 
 squeezing or picking at blemishes, 
 Hard scrubbing of the skin. 
Increase in hormonal activityespecially duringpuberty, may 
cause the formation of acne. The most important cause 
attributed is infections due to Propionibacterium acnes (P. 
acnes), the anaerobic bacterium species [23] 
 
Figure 3: A severe case of nodular acne [20] 
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Figure 4: Nodular acne on the back [21] 
INCIDENCE OF ACNE 
Acne is a common condition which affects millions of 
adolescents and adults. Adult acne is less common than 
adolescent acne. But, still it is a problem for 3% to 6% of adult 
men and 5% to 12% of adult women. It was estimated that acne 
affects 54% of women and 40% of men older than 25 years of 
age [24][25]. In those over 40 years old, 1% of males and 5% 
of females still have problems [2]. In 2013, acne was estimated 
to affect 660 million people globally, making it the 8th most 
common disease worldwide [26] - [29]. It is slightly more 
common in females than males (9.8% versus 9.0%) [30]. 
Although the presence of acne does not physically impair 
patients, it can have a remarkable psychological effect. Thirty 
to fifty percent of adolescents experience psychiatric 
disturbances as the result of acne. While some research has 
found it affects people of all ethnic groups [28]. The social and 
economic costs of treating acne vulgaris are substantial. In the 
United States, Acne vulgaris is responsible for more than 
5 million doctor visits and costs over US$2.5 billion each year 
in direct costs. Similarly, acne vulgaris is responsible for 
3.5 million doctor visits each year in the United Kingdom [2]. 
The FDA has issued a warning that certain over the counter 
topical acne products may cause rare but serious and 
potentially life threatening allergic reactions or severe 
irritation. Users who experience hypersensitivity reactions such 
as throat tightness, difficulty in breathing, feeling faint or 
swelling of the eyes, face, lips or tongue or who develops hives 
or itching should stop using the products and seek immediate 
emergency medical attention [31][32] 
 
PATHOGENESIS OF ACNE 
The pathogenesis of acne vulgaris is multifactorial. The key 
factor is genetics [33]. Acne develops due to following four 
factors: [34] 
 Release of inflammatory mediators into the skin 
 Follicular hyperkeratinization and then plugging of the 
follicle 
 follicular colonization of Propionibacterium acnes 
 Excess sebum production 
 
Figure 5: Acne pathogenesis [35] 
It was found that the inflammatory responses occur before 
hyper keratinization. Cytokines and macrophages regulate 
inflammatory mediators such as vascular cell adhesion 
molecule-1 (VCAM-1), intercellular adhesion molecule-1 
(ICAM-1), and human leukocyte antigen (HLA)–DR in the 
vessels around the pilosebaceous follicle [36]. Follicular 
hyperkeratinization involves increased keratinocyte 
proliferation and decreased desquamation, leading to sebum- 
and keratin-filled microcomedones [37] 
P acnesis an anaerobic organism present in acne lesions. The 
presence of P acnes promotes inflammation through a variety 
of mechanisms. P acnes stimulate inflammation by producing 
proinflammatory mediators that diffuse through the follicle 
wall. Studies have shown that P acnes activate the toll-like 
receptor 2 on monocytes and neutrophils [38]. Activation of the 
toll-like receptor 2 then leads to the production of multiple 
proinflammatory cytokines, including interleukins 12 and 8 and 
tumour necrosis factor. Hypersensitivity to P acnes may also 
explain why some individuals develop inflammatory Acne 
vulgaris while others do not [39]. 
 
Excess sebum is another key factor in the development of Acne 
vulgaris. Sebum production and excretion are regulated by a 
number of different hormones and mediators. In particular, 
androgen hormones promote sebum production and release 
[40]. The degree of comedonal acne in prepubertal girls 
correlates with circulating levels of the adrenal androgen 
dehydroepiandrosterone sulfate (DHEA-S) [41]. Numerous 
other mediators and receptors, including growth hormone and 
insulinlike growth factor, as well as peroxisome proliferator-
activated receptors also regulate the sebaceous gland and may 
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contribute to the development of acne [42][43]. Furthermore, 
the sebaceous gland acts a neuroendocrine-inflammatory organ 
that is activated via corticotrophin-releasing hormones in 
response to stress and normal functions [44] 
 
DIAGNOSIS 
Several scales exist to grade the severity of Acne vulgaris, but 
no single technique has been universally accepted as the 
diagnostic standard [45][46]. Cook's acne grading scale uses 
photographs to grade severity from 0 to 8 (0 being the least 
severe and 8 being the most severe) [46]. Leeds acne grading 
technique counts acne lesions on the face, back, and chest and 
categorizes them as inflammatory or non-inflammatory. Leeds 
scores range from 0 (least severe) to 10 (most severe) though 
modified scales have a maximum score of 12 [46][47]. The 
Pillsbury acne grading scale simply classifies the severity of 
the acne from 1 (least severe) to 4 (most severe) [45][48] 
 
ACNE TREATMENT  
In the present scenariovarious therapies include: 
Topical Therapy includes benzoyl peroxide available in 
different formulations such as washes, lotions, creams, and gels 
with concentrations (2.5–10%). It does not cause bacterial 
antibiotic resistance like antibiotics [49]. However topical 
retinoids such as tretinoin, adapalene, isotretinoin, metretinide, 
retinaldehyde, tazarotene, and β-retinoylglucuronideare 
currently used [50]. In Combination therapy Benzoyl peroxide 
[12]is used with topical erythromycin or clindamycin. Benzoyl 
peroxide could also be used with tretinoin and considered 
superior. Topical retinoid in combination with topical 
antimicrobial is found to be more effective in reducing both 
inflammatory and non inflammatory acne lesions. 
Systemic therapy: For moderate to severe inflammatory acne 
oral antibiotics such as tetracyclinesare used currently. 
Macrolides, co-trimoxazole, and trimethoprim are other 
alternatives for acne. Cephalosporins and sulphonamide, should 
not be used in acne due to lack of efficacy and safety. 
Gastrointestinal upset and vaginal candidiasis are most 
common side effects. Isotretinoin is an oral retinoid and is 
found to be very effective for severe nodular acne [2][51]. It 
requires one to two months of isotretinoin therapy for severe 
nodular acne. It takes a 4–6 month to treat acne completely by 
the use of oral isotretinoin [51]. After a single course, about 
80% of people report an improvement, with more than 50% 
reporting complete remission [2]. About 20% of people require 
a second course [2]. There is no clear evidence that use of oral 
retinoids increases the risk of psychiatric side effects such as 
depression and suicidality [2][51]. Isotretinoin use in women of 
childbearing age is strictly regulated due to its known harmful 
effects in pregnancy [2]. For a woman of childbearing age to be 
considered a candidate for isotretinoin, she must have a 
confirmed negative pregnancy test and use an effective form of 
birth control [2] 
 
Harmonal therapy may be needed in female patients with 
severe seborrhoea, clinically apparent androgenetic alopecia, 
seborrhea /acne /hirsuitism /alopecia (SAHA) syndrome, late-
onset acne (acne tarda), and with proven ovarian or adrenal 
hyperandrogenism. The main approach of hormonal therapy in 
acne is to prevent the effects of androgens on the sebaceous 
gland and probably follicular keratinocytes as well. Oral 
antiandrogen like spironolactone and cyproterone acetate can 
be useful in the treatment of acne. 
 
Physical Treatment: Both open and closed comedones can be 
removed with comedone extractor, a fine needle or a pointed 
blade mechanically. Topical retinoid application before this 
procedure makes it easier. Gentle cautery and laser puncture of 
macro comedones can also be done. The limitations include 
incomplete extraction, refilling, and the risk of tissue damage. 
 
ACNE SCARS 
Acne scars are caused by abnormal healing followed by 
inflammation within the dermal layer of skin. It is estimated to 
affect 95% of people with Acne vulgaris [52]. It is most likely 
to take place with severe nodular acne, but may occur with any 
form of Acne vulgaris [52]. Acne scar can be broadly divided 
into two groups, those involving tissue losses (Ice pick scar, 
Box scar, Rolling scar, and Follicular macular atrophy) and 
those involving tissue excess (hypertrophic scars or keloids).  
 Ice-pick scars are narrow (less than 2 mmacross), deep scars 
that extend into the dermis. Boxcar scars are round or ovoid 
indented scars with sharp borders and vary in size from 1.5–
4 mm across [52]. Rolling scars are wider than ice pick and 
boxcar scars (4–5 mm across) and have a wave-like pattern of 
depth in the skin [52] 
 
Hypertrophic scars are characterized by increased collagen 
content after the abnormal healing response [52]. They are 
described as firm and raised from the skin [52][53]. 
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Hypertrophic scars remain within the original margins of the 
wound, whereas keloid scars can form scar tissue outside of 
these borders [52].  
 
Keloid scars from acne occur more often in men and people 
with darker skin, and usually occur on the trunk of the body 
[52]. Currently available treatment for scars include simple 
excision, and suturing, either alone or combined with punch 
grafting and laser resurfacing, dermabrasion, various type of 
lasers, chemical peels, and fillers. For hypertrophic scars, 
treatment includes pressure therapy, IL corticosteroid, 5-
fluorouracil and bleomycin injections, surgical excision, 
radiotherapy, laser therapy and cryotherapy. All the procedures 
have their own merits and demerits; to be chosen carefully 
seeing the merit [53] 
 
ACNE AND DIET  
Dietary restriction has not been proved to be of any benefit in 
the treatment of acne. It is a myth that diet affects acne but 
studies are not supporting it. Various authors are still claiming 
that there is the definite role of diet in acne but to conclude that 
further controlled trials are needed. It was considered that low 
occurrence of acne in rural, and non industrialized societies are 
may be due to lower glycemic index diet.  
 
CONCLUSION 
Acne is characterized by blackheads, whiteheads and 
inflammatory papules which mainly affects adolescents. 
Adolescent stage is a complex life cycle characterized by many 
biological, physical, psychological and social changes. The 
physical changes of acne may have negative effect on the 
psychology, quality of life and self-esteem of adolescents. 
Although many oral and topical medical agents have been 
found to be effective in the treatment of acne, the prevalence of 
the disease make the development of alternative therapies 
highly desirable. There has been significant progress over the 
past few years, but not all developments can be universally 
applied. 
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